Andecaliximab

Tax included
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF).
MedChemExpress 
HY-P99351

Data sheet

Size
Multiple sizes
Reactivity
MMP
Application
Cancer-Kinase/protease
CAS
1518996-49-0